KSA Asthma Exam 2025 With 100%
Correct Answers
A 26-year-old male with asthma is seen in the emergency department. He is short of breath to a
degree that makes it difficult to speak in sentences and he appears tired. On examination you
note diminished breath sounds with an occasional wheeze. His FEV1 is 15% of predicted and his
pCO2 is 45 mm Hg. He is given albuterol (Proventil, Ventolin) over the next hour but he has a
poor response. He is not able to repeat the spirometry and he now appears drowsy. Which one
of the following would be consistent with imminent respiratory failure? - CORRECT
ANSWER✔✔E. The absence of wheezes
Which one of the following is true regarding leukotriene modifiers for treatment of asthma in
adults? - CORRECT ANSWER✔✔D. They are less effective than inhaled corticosteroids (ICSs)
Chronic low- to medium-dose inhaled corticosteroid use in children is associated with -
CORRECT ANSWER✔✔E. no long-term adverse effects
An 18-year-old female presents to your office with a history of wheezing, coughing, and year-
round symptoms of rhinitis. She reports that her symptoms occur several times a week but
rarely more than once a day, except in the last year, when she has had to intermittently use
albuterol (Proventil, Ventolin) every day for a week at a time. She wakes up with nighttime
coughing weekly, with no fever or other symptoms, and tells you that the coughing is severe
enough to make her cat jump off the bed. Albuterol helps her symptoms temporarily. She has
been treated with oral corticosteroids on three occasions this past year, most recently 6 weeks
ago. Her Asthma Control Test score is 17. Pre- and postbronchodilator spirometry results are
shown below.
Initial testing
FVC............2.0 L (80% of predicted)
FEV1............1.4 L (70% of predicted)
FEF 25-75............1.5 L/sec (89% of predicted)
, 15 minutes post bronchodilator - CORRECT ANSWER✔✔A. Budesonide/formoterol (Symbicort),
with an increase in dosage for exacerbations
A 22-year-old female presents to your office with an acute asthma attack that developed 2 days
after the onset of a viral upper respiratory infection. Her asthma is usually well controlled, with
a personal best peak expiratory flow (PEF) of 380 L/min. On initial evaluation by the nurse she
has a pulse rate of 120 beats/min, a respiratory rate of 32/min, and an oxygen saturation of 92%
on room air. On examination she is very dyspneic with diffuse inspiratory and expiratory
wheezing and she is using accessory muscles to breathe. Her PEF is 150 L/min. Inhaled β-
agonists and systemic corticosteroids are administered and she is reevaluated 1 hour later.
Which one of the following would provide the most reassurance that she is responding to
therapy? - CORRECT ANSWER✔✔C. A PEF of 310 L/min
You are counseling a patient with moderate persistent asthma about the value of following a
written asthma action plan. To encourage her to use an asthma action plan you share the results
of studies that document their benefit in optimizing asthma control and reducing future risk.
Which one of the following is an accurate statement regarding asthma action plans? - CORRECT
ANSWER✔✔D. The lack of a written asthma action plan is a risk factor for death from asthma
A 28-year-old female presents with progressively worsening asthma after a recent viral upper
respiratory infection. When you enter the room, she appears in distress and is only able to talk
in words, not sentences. Her respiratory rate is 34/min and her heart rate is 126 beats/min. Her
oxygen saturation before oxygen was administered was 89%. You begin treatment with a
nebulized short-acting β-agonist (SABA) plus ipratropium and give an initial dose of oral
prednisone. After one hour her symptoms are not responsive to initial treatment efforts.
Which one of the following should you consider as a possible adjunctive treatment? - CORRECT
ANSWER✔✔C. Intravenous magnesium sulfate
Which one of the following is true regarding regular use of inhaled corticosteroids (ICSs) in
patients with persistent asthma? - CORRECT ANSWER✔✔A. Oral candidiasis is a potential side
effect of ICS use
Correct Answers
A 26-year-old male with asthma is seen in the emergency department. He is short of breath to a
degree that makes it difficult to speak in sentences and he appears tired. On examination you
note diminished breath sounds with an occasional wheeze. His FEV1 is 15% of predicted and his
pCO2 is 45 mm Hg. He is given albuterol (Proventil, Ventolin) over the next hour but he has a
poor response. He is not able to repeat the spirometry and he now appears drowsy. Which one
of the following would be consistent with imminent respiratory failure? - CORRECT
ANSWER✔✔E. The absence of wheezes
Which one of the following is true regarding leukotriene modifiers for treatment of asthma in
adults? - CORRECT ANSWER✔✔D. They are less effective than inhaled corticosteroids (ICSs)
Chronic low- to medium-dose inhaled corticosteroid use in children is associated with -
CORRECT ANSWER✔✔E. no long-term adverse effects
An 18-year-old female presents to your office with a history of wheezing, coughing, and year-
round symptoms of rhinitis. She reports that her symptoms occur several times a week but
rarely more than once a day, except in the last year, when she has had to intermittently use
albuterol (Proventil, Ventolin) every day for a week at a time. She wakes up with nighttime
coughing weekly, with no fever or other symptoms, and tells you that the coughing is severe
enough to make her cat jump off the bed. Albuterol helps her symptoms temporarily. She has
been treated with oral corticosteroids on three occasions this past year, most recently 6 weeks
ago. Her Asthma Control Test score is 17. Pre- and postbronchodilator spirometry results are
shown below.
Initial testing
FVC............2.0 L (80% of predicted)
FEV1............1.4 L (70% of predicted)
FEF 25-75............1.5 L/sec (89% of predicted)
, 15 minutes post bronchodilator - CORRECT ANSWER✔✔A. Budesonide/formoterol (Symbicort),
with an increase in dosage for exacerbations
A 22-year-old female presents to your office with an acute asthma attack that developed 2 days
after the onset of a viral upper respiratory infection. Her asthma is usually well controlled, with
a personal best peak expiratory flow (PEF) of 380 L/min. On initial evaluation by the nurse she
has a pulse rate of 120 beats/min, a respiratory rate of 32/min, and an oxygen saturation of 92%
on room air. On examination she is very dyspneic with diffuse inspiratory and expiratory
wheezing and she is using accessory muscles to breathe. Her PEF is 150 L/min. Inhaled β-
agonists and systemic corticosteroids are administered and she is reevaluated 1 hour later.
Which one of the following would provide the most reassurance that she is responding to
therapy? - CORRECT ANSWER✔✔C. A PEF of 310 L/min
You are counseling a patient with moderate persistent asthma about the value of following a
written asthma action plan. To encourage her to use an asthma action plan you share the results
of studies that document their benefit in optimizing asthma control and reducing future risk.
Which one of the following is an accurate statement regarding asthma action plans? - CORRECT
ANSWER✔✔D. The lack of a written asthma action plan is a risk factor for death from asthma
A 28-year-old female presents with progressively worsening asthma after a recent viral upper
respiratory infection. When you enter the room, she appears in distress and is only able to talk
in words, not sentences. Her respiratory rate is 34/min and her heart rate is 126 beats/min. Her
oxygen saturation before oxygen was administered was 89%. You begin treatment with a
nebulized short-acting β-agonist (SABA) plus ipratropium and give an initial dose of oral
prednisone. After one hour her symptoms are not responsive to initial treatment efforts.
Which one of the following should you consider as a possible adjunctive treatment? - CORRECT
ANSWER✔✔C. Intravenous magnesium sulfate
Which one of the following is true regarding regular use of inhaled corticosteroids (ICSs) in
patients with persistent asthma? - CORRECT ANSWER✔✔A. Oral candidiasis is a potential side
effect of ICS use
